supervilitrra

Super Vilitra combines two active ingredients: Vardenafil and Dapoxetine. Vardenafil is a phosphodiesterase-5 (PDE-5) inhibitor that relaxes blood vessels and improves blood flow, primarily used to treat erectile dysfunction. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat premature ejaculation. While Super Vilitra is not specifically approved for PAH, the PDE-5 inhibition provided by Vardenafil offers potential benefits for PAH patients by promoting vasodilation and improving blood flow in the pulmonary arteries.